Nifedipine Activase Pharmaceuticals

Nifedipine, the active ingredient in Nifedipine Activase Pharmaceuticals, is a calcium channel blocker presented as an oral formulation for oral use. It is employed to manage hypertension, chronic stable angina and Raynaud's phenomenon in adult patients.\n\nGNH India supplies Nifedipine Activase Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nifedipine acts on the vascular smooth‑muscle calcium channels to lower blood pressure and improve coronary blood flow.\n\n- Hypertension: reduces peripheral vascular resistance to achieve target blood pressure levels.\n- Chronic stable angina: alleviates chest pain by enhancing myocardial oxygen supply.\n- Raynaud's phenomenon: diminishes vasospasm in peripheral arteries to improve blood flow to the extremities.

Nifedipine may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Headache: mild to moderate pain often occurring after dose initiation.\n- Flushing: transient warmth and redness of the skin.\n- Peripheral edema: swelling of ankles or lower legs.\n- Dizziness or light‑headedness, especially when standing.\n- Tachycardia: increased heart rate as a reflex response.\n- Nausea: occasional gastrointestinal discomfort.\n\nSerious or Rare Side Effects:\n- Severe hypotension: marked drop in blood pressure requiring medical attention.\n- Myocardial infarction: rare occurrence of heart attack.\n- Life‑threatening arrhythmias: abnormal heart rhythms.\n- Hepatic dysfunction: elevated liver enzymes or hepatitis.\n- Anaphylaxis or severe allergic reaction.\n- Blood pressure crisis: uncontrolled hypertension or hypotension.

Before initiating therapy, consider patient‑specific factors and monitor for adverse events.\n\n- Blood pressure monitoring: check regularly to ensure therapeutic response.\n- Avoid abrupt discontinuation: taper dose to prevent rebound hypertension.\n- Hepatic impairment: use with caution and adjust dose if needed.\n- Elderly patients: start at lower dose due to increased sensitivity.\n- Grapefruit juice: avoid as it can increase plasma concentrations.\n- Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Nifedipine can interact with several drug classes, altering its efficacy or safety profile.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may cause toxic plasma levels.\n- High‑dose simvastatin: increased risk of myopathy.\n- Other potent antihypertensives: additive hypotensive effect.\n\nModerate Interactions (Monitor Closely):\n- Diltiazem or verapamil: may enhance vasodilatory effect.\n- Beta‑blockers: combined effect on heart rate and blood pressure.\n- Diuretics: may potentiate orthostatic hypotension.\n- Alcohol: can increase dizziness and hypotension.